Keith Wilson

Director, Manufacturing Science and Technology at Century Therapeutics, Inc., USA

Keith has 15 years of industry experience in the cell therapy development and operations space. He is currently the Director of Manufacturing Science and Technology (MSAT) at Century Therapeutics, leading the implementation, support, and scale up of Century’s manufacturing processes into a new in-house facility. Prior to Century, Keith was at Celgene/ Bristol Myers Squibb for 14 years in the cell therapy space. He most recently led the clinical manufacturing team in successful execution of a pivotal CAR T trial, as well as several Phase I trials. Prior to that he held roles of increasing responsibility in Process Development and tech transfer, with expertise in both autologous and allogenic cell therapies, across multiple cell types. Keith received his Masters and Bachelors of Biomedical Engineering at Stevens Institute of Technology in Hoboken, NJ.